Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 3 studies | 23% ± 1% |
Insufficient scRNA-seq data for expression of ARSK at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 320.34 | 2611 / 2642 | 99% | 6.94 | 701 / 705 |
| ovary | 100% | 495.41 | 180 / 180 | 98% | 6.68 | 422 / 430 |
| thymus | 100% | 490.60 | 653 / 653 | 98% | 6.72 | 592 / 605 |
| prostate | 100% | 571.02 | 245 / 245 | 97% | 7.86 | 488 / 502 |
| kidney | 100% | 329.89 | 89 / 89 | 97% | 9.18 | 875 / 901 |
| uterus | 99% | 521.12 | 169 / 170 | 97% | 6.69 | 443 / 459 |
| lung | 100% | 412.35 | 576 / 578 | 96% | 5.05 | 1111 / 1155 |
| breast | 100% | 446.15 | 459 / 459 | 93% | 5.47 | 1037 / 1118 |
| esophagus | 100% | 348.85 | 1441 / 1445 | 93% | 4.89 | 170 / 183 |
| skin | 100% | 591.68 | 1807 / 1809 | 92% | 8.32 | 435 / 472 |
| stomach | 100% | 469.23 | 359 / 359 | 91% | 3.97 | 261 / 286 |
| pancreas | 98% | 350.94 | 323 / 328 | 91% | 4.61 | 162 / 178 |
| intestine | 100% | 392.43 | 965 / 966 | 87% | 3.77 | 456 / 527 |
| bladder | 100% | 499.33 | 21 / 21 | 84% | 3.96 | 421 / 504 |
| liver | 100% | 271.28 | 225 / 226 | 79% | 3.70 | 322 / 406 |
| adrenal gland | 100% | 538.32 | 258 / 258 | 72% | 5.00 | 166 / 230 |
| adipose | 100% | 438.32 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 566.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 278.53 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 7.06 | 44 / 45 |
| muscle | 95% | 191.18 | 763 / 803 | 0% | 0 | 0 / 0 |
| heart | 94% | 234.09 | 806 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 2.90 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 79% | 4.54 | 63 / 80 |
| peripheral blood | 38% | 123.35 | 349 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005764 | Cellular component | lysosome |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0015024 | Molecular function | glucuronate-2-sulfatase activity |
| GO_0004065 | Molecular function | arylsulfatase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ARSK |
| Protein name | Arylsulfatase family member K ARSK protein Arylsulfatase K (ASK) (EC 3.1.6.1) (Glucuronate-2-sulfatase) (EC 3.1.6.18) (Telethon sulfatase) |
| Synonyms | UNQ630/PRO1246 TSULF |
| Description | FUNCTION: Catalyzes the hydrolysis of pseudosubstrates such as p-nitrocatechol sulfate and p-nitrophenyl sulfate . Catalyzes the hydrolysis of the 2-sulfate groups of the 2-O-sulfo-D-glucuronate residues of chondroitin sulfate, heparin and heparitin sulfate . Acts selectively on 2-sulfoglucuronate and lacks activity against 2-sulfoiduronate . . |
| Accessions | D6R9F9 ENST00000504873.5 ENST00000380009.9 ENST00000504763.1 ENST00000513814.5 Q86W75 D6RBR4 E9PGI0 ENST00000512106.1 H0Y9F6 Q6UWY0 |